Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension

Kidney International

Volumn 54, Issue 2, 1998, Pages 482-491

  Vaziri, Nosratola D ^a,b   Zhenmin, Ni ^a   Zhang, Yan Ping ^a   Ruizcs, Ervin P ^a   Maleki, Pejman ^a   Ding, Yaoxian ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclosporine; Hypertension; Nephrotoxicity; Nitric oxide; Transplantation; Vasculopathy

Indexed keywords

ARGININE; CYCLOSPORIN; MESSENGER RNA; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NITROPRUSSIDE SODIUM; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; INTRAGASTRIC DRUG ADMINISTRATION; KIDNEY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; URINARY EXCRETION;

EID: 7344249590     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00014.x     Document Type: Article

References (49)

1. THE CANADIAN MULTICENTRE TRANSPLANT STUDY GROUP: A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 309:809-815, 1983
2. MYERS BD: Cyclosporine nephrotoxicity. Kidney Int 30:964-974, 1986
3. KAHAN BD: Cyclosporine. N Engl J Med 324:1725-1738, 1989
4. BELLET M, CABROL C, SASSANO P, LEGER P, CORVOL P, MENARD J: Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensin system. Am J Cardiol 56:927-931, 1985
5. CHAPMAN JR, MARCEN R, ARIAS M, RAINE AEG, DUNNILL MS, MORRIS PJ: Hypertension after cardiac transplantation: A comparison of cyclosporine and conventional immunosuppression. Transplantation (Baltimore) 43:860-864, 1987
6. WHITWORTH JA, MILLS EH, COGHLAN JP: The haemodynamic effects of cyclosporin A in sheep. Clin Exp Pharmacol Physiol 14:573-580, 1987
7. MIKKELSEN EO, POULSEN SH, NYBORG NCB, KORSGAARD N, SEHESTED J: Difference between aortic and renal vascular reactivity in cyclosporin A treated rats and the effect of cicletanine. Arch Pharmacol 345:356-361, 1992
8. RAINE AEG, CARTER R, MANN JI, MORRIS PJ: Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients. Nephrol Dial Transplant 3:458-463, 1988
9. KASISKE BL, TORTORICE KL, HEIM-DUTHOY KL, AWNI WM, RAO KV: The adverse impact of cyclosporin on serum lipids in renal transplant patients. Am J Kidney Dis 17:700-707, 1991
10. GALLEGO MJ, FARRE AL, RIESCO A, MONTON M, GRANDES SM, BARAT A, HERNANDO L, CASADO S, CARAMELO CA: Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: Effect of L-arginine. Am J Physiol 264:H708-H714, 1993
11. REGO A, VARGAS R, FOEGH ML, RAMWELL PW: Effect of cyclosporine A treatment on vascular reactivity of the rat thoracic aorta. Transplant Proc 20:572-577, 1988
12. REGO A, VARGAS R, WROBLEWSKA B, FOEGH ML, RAMWELL PW: Attenuation of vascular relaxation and cyclic GMP responses by cyclosporin A. J Pharmacol Exp Ther 252:165-170, 1990
13. ROULLET JB, XUE H, MCCARRON DA, HOLCOMB S, BENNETT WM: Vascular mechanisms of cyclosporine-indueed hypertension in rat. J Clin Invest 93:2244-2250, 1994
14. 2+. Circ Res 74:477-484, 1994
15. TAKENAKA T, HASHIMOTO Y, EPSTEIN M: Diminished acetylcholine-induced vasodilation in renal microvessels of cyclosporine-treated rats. J Am Soc Nephrol 3:42-50, 1992
16. SUDHIR K, MACGREGOR JS, DE MARCO T, DE GROOT CJM, TAYLOR RN, CHOU TM, YOCK PG, CHATTERJEE K: Cyclosporine impairs release of endothelium-derived relaxing factor in epicardial and resistant coronary arteries. Circulation 90:3018-3023, 1994
17. RICHARDS NT, POSTON L, HILTON PJ: Cyclosporine A inhibits relaxation hut does not induce vasoconstriction in human subcutaneous resistance vessels. J Hypertens 7:1-3, 1989
18. SOLAGNI K, MARTASEK P, SCHWARTZMAN M, KORCZEK L, GOODMAN A, ABRAHAM N, LEVERE RD: L-arginine protects cyclosporin A-induced blood pressure elevation in spontaneously hypertensive rats. Clin Res 38:349, 1990
19. MARTIN PY, XU DL, NIEDERBERGER M, WEIGERT A, TSAI P, ST JOHN J, GINES P, SCHRIER RW: Upregulation of endothelial constitutive NOS: A major role in the increased No production in cirrhotic rats. Am J Physiol (Renal Fluid Electrol Physiol) 270:F494-F499, 1996
20. COMINI L, BACHETTI T, GAIA G, PASINI E, AGNOLETTI L, PEPI P, CECONI C, CURELLO S, FERRARI R: Aorta and skeletal muscle NO synthase expression in experimental heart failure. Mol Cell Cardiol 28:2241-2248, 1996
21. ARNAL JF, YAMIN J, DOCKERY S, HARRISON DG: Regulation of endothelial nitric oxide synthase mRNA protein and activity during cell growth. Am J Physiol 267:C1381-C1388, 1994
22. NI Z, MORCOS S, VAZIRI ND: Upregulation of renal and vascular nitric oxide synthase in iron-deficiency anemia. Kidney Int 52:195-201, 1997
23. HUTCHESON AE, RAO MR, OLINDE KD, MARKOV AK: Myocardial toxicity of cyclosporine A: Inhibition of calcium ATPase and nitric oxide synthase activities and attenuation by fructose-1,6-diphosphate in vitro. Res Commun Mol Pathol Pharmacol 89:17-26, 1995
24. RAIJ L, BAYLIS C: Glomerular actions of nitric oxide. Kidney Int 48:20-32, 1995
25. NAVAR LG, INSCHO EW, MAJID SA, IMIG JD, HARRISON BERNARD LM, MITCHELL KD: Paracrinc regulation of the renal microcirculation. Physiol Rev 76:425-536, 1996
26. PATEL AR, GRANGER JP, KIRCHNER KA: L-arginine improves transmission of perfusion pressure to the renal interstitium in Dahl salt-sensitive rats. Am J Physiol 266:R1730-R1735, 1994
27. HALL JE, GUYTON AC, BRANDS MW: Pressure-volume regulation in hypertension. Kidney Int 55:535-541, 1996
28. STOOS BA, GARCIA NH, GARVIN JL: Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol 6:89-94, 1995
29. GARCIA NH, STOOS BA, CARRETERO OA, GARVIN JL: Mechanism of the nitric oxide induced blockade of collecting duct water permeability. Hypertension 27:679-683, 1996
30. STOOS BA, GARVIN JL: Inhibition of Cl absorption (JCI) by NO produced in the thick ascending limb (THAL) by endogenous nitric oxide synthase (NOS) increases during salt loading, (abstract) J Am Soc Nephrol 7:1291, 1996
31. DENG A, BAYLIS C: Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol 264:F212-F215, 1993
32. ITO S, JOHNSON CS, CARRETERO OA: Modulation of angiotensin II induced vasoconstriction by endothelium derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 87:1656-1663, 1991
33. SALAZAR FJ, ALBEROLA A, PINILLA JM, ROMERO JC, QUESADA T: Salt induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 22:49-55, 1993
34. SHULTZ PJ, TOLINS JP: Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. J Clin Invest 91:642-650, 1993
35. TOLINS JP, SHULTZ PJ: Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 46:230-236, 1994
36. FENOY FJ, FERRER P, CARBONELL L, GARCIA SALOM M: Role of nitric-oxide on papillary blood flow and pressure natruresis. Hypertension 25:408-414, 1995
37. MATTSON DL, LU S, NAKANISHI K, PAPANEK PE, COWLEY AW JR: Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol 266:H1918-H1926, 1994
38. HU L, MANNING RD JR: Role of nitric oxide in regulation of long-term pressure natruresis relationship in Dahl rats. Am J Physiol 268:H2375-H2383, 1995
39. GUARASCI GR, KLINE RL: Pressure natruresis following acute and chronic inhibition of nitric oxide synthase in rats. Am J Physiol 270:R469-R478, 1996
40. MAJID DSA, WILLIAMS A, KADOWITZ PJ, NAVAR LG: Renal responses to intra-arterial administration of nitric oxide donors in dogs. Hypertension 22:535-541, 1993
41. GRACE AA, BARRADAS MA, MIKHAILIDIS DP, JEREMY JY, MOOREHEAD JF, SWENY PS, DANADONA P: Cyclosporin enhances platelet aggregation. Kidney Int 32:889-895, 1987
42. MOHAUPT MG, ELZIE JL, AHN KY, CLAPP WL, WILCOX CS, KONE BC: Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int 46:653-665, 1994
43. MORRISSEY JJ, MCCRACKEN R, KANETO H, VEHASKARI M, MONTANI D, KLAHR S: Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 45:998-1005, 1994
44. MATTSON DL, HIGGINS DJ: Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension 27:688-692, 1996
45. VAZIRI ND, NI Z, OVEISI F: Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31:1248-1254, 1998
46. GONICK HC, DING Y, BONDY SC, NI Z, VAZIRI ND: Lead-induced hypertension. Interplay of nitric oxide and reactive oxygen species. Hypertension 30:1487-1492, 1997
47. VAZIRI ND, NI Z, WANG XQ, OVEISI F, ZHOU XJ: Down -regulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH. Am J Physiol (Renal Physiol) 274:F642-F649, 1998
48. HEDAYATI S, BERNAREGGI A, ROWLAND M: Absorption kinetics of cyclosporin in the rat. J Pharm Pharmacol 44:122-124, 1992
49. RAO MR, KANJI VK, SETTY VV, WANG C, SALAHUDEEN AK, DAS SK, COHLY HH: Cyclosporin A-induced changes in nitric oxide synthase activity in the rat kidney: In vitro and in vivo assay. Indian J Physiol Pharmacol 40:183-185, 1996